Testicular Cancer
📧 Sign up to get email alerts when something new happens for Testicular Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Results: Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating a gemcitabine, oxaliplatin, and paclitaxel regimen in patients with refractory germ cell carcinoma (testic…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Cause of Familial Testicular Cancer
Clinical trial update summarizing findings on the genetic or familial factors contributing to testicular cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors [Phase 1]
Context Therapeutics reports an ongoing Phase 1 study of CTIM-76 in platinum-resistant ovarian cancer and other advanced solid tumors, with …
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Role of Axumin PET Scan in Germ Cell Tumor
This clinical trial evaluated the role of Axumin PET imaging in germ cell tumors, including testicular cancer. The study status is completed…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
A clinical trial investigating late subclinical cardiovascular disease in testicular cancer survivors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
A terminated Mayo Clinic trial investigated associations between chemotherapy-induced nausea in genitourinary, sarcoma, and melanoma cancers…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Testicular Self-Examination Awareness in Young Men [NA]
A Hitit University-sponsored clinical trial evaluating awareness of testicular self-examination in young men has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Study of SGN-ALPV in Advanced Solid Tumors [Phase 1]
Seagen's Phase 1 study of SGN-ALPV in advanced solid tumors has been terminated; the trial evaluated multiple cancers including ovarian, end…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours [Phase 3]
Phase 3 trial evaluating one cycle of adjuvant BEP chemotherapy in high-risk stage I non-seminomatous germ cell tumor of the testis; the tri…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors [Phase 2]
A Phase 2 trial evaluating high-dose chemotherapy for patients with poor-prognosis relapsed germ-cell tumors (testicular cancer) has complet…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Short-term Testosterone Replacement in Testicular Cancer Survivors [Phase 2]
A Phase 2 clinical trial evaluating short-term testosterone replacement in survivors of testicular cancer has completed. The study was condu…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1]
A phase 1 trial evaluating CLDN6/GPC3/Mesothelin/AXL-CAR-NK cell therapy for advanced solid tumors is currently recruiting, including stage …
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Vascular Fingerprint Validation Study
The University Medical Center Groningen reports that the Vascular Fingerprint Validation Study for testicular cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Mental Health of Men Before and After Testicular Cancer Treatment
The study completed its evaluation of mental health outcomes in men with testicular cancer before and after treatment, including cognitive f…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
A completed pilot clinical trial evaluating knowledge and attitudes toward healthy lifestyle and health behavior change among cancer patient…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity
This completed clinical trial investigates cardiovascular morbidity risk factors and pharmacogenomic determinants of toxicity in survivors o…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Taste, Smell and Chemotherapy (TASTY) [Phase 4]
Phase 4 clinical trial update for the TASTY study evaluating taste and smell changes with chemotherapy in testicular cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [Phase 2]
Phase 2 clinical trial evaluating FalateScan (Technetium Tc 99m EC20) for safety and efficacy in patients with suspected recurrent or metast…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer [Phase 3]
A Phase 3 trial evaluating the addition of olanzapine to fosaprepitant, ondansetron, and dexamethasone for preventing chemotherapy-induced n…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer [Phase 2]
Phase 2 trial update evaluating gemcitabine, carboplatin, and veliparib (ABT-888) in refractory testicular germ cell cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Biobehavioral Intervention for Young Men With Testicular Cancer [Phase 2]
Phase 2 clinical trial updating a biobehavioral intervention for young men with testicular cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Study of Testosterone vs Placebo in Testicular Cancer Survivors [Phase 2, Phase 3]
Phase 2/3 trial comparing testosterone versus placebo in testicular cancer survivors, with focus on metabolic syndrome and Leydig cell failu…
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors [Phase 2]
Phase 2 trial of brentuximab vedotin in relapsed/refractory germ cell tumors was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Carboplatin AUC-10 With Early PET Scanning in Metastatic Seminoma [Phase 2]
Phase 2 trial evaluating carboplatin AUC-10 with early PET scanning in metastatic seminoma has completed and results are posted.